Kiwon lafiya, Shirye-shirye
"Etaperazin" wajen. Umarnin don amfani
Medicine "Etaperazin", farashin 250 rubles ne neuroleptic (antipsychotic) piperazine phenothiazine Kalam.
ganawa
Na nufin "Etaperazin" umurci manual bada shawarar domin lura da shafi tunanin mutum da cuta kamar, tare da tashin hankali da kuma Hyperactivity. By alamomi sun hada da schizophrenia, neurosis, wahala da tashin hankali, da tsoro. Da miyagun ƙwayoyi ne nuna ga fata ulcers, don kawar da amai ko tashin zuciya daban-daban yanayi bayyana.
"Etaperazin" magani.
Umarnin don amfani
The shawarar kashi ga marasa lafiya shekaru 12 - 4-80 MG. A kan tushen da kullum pathologies daga ƙarƙashinsu adadin da miyagun ƙwayoyi da aka jiyar (da gwani shawarwari) ta ƙara zuwa 150-400 MG. Duration liyafar ta mita a kowace rana aka ƙaddara na musamman da likita.
illa
Na nufin "Etaperazin" (umurci manual yayi kashedin game da shi) zai iya haifar da extrapyramidal halayen parkinsonian da dystonic irin melasma, cholestatic jaundice, Heart hangen nesa, photosensitivity. Illa hada akathisia, fata na gaggawa, tare da dermatitis, drowsiness, wahalar yana yin fitsari. Bisa ga lura shi ne wata ila a take hakkin masauki, bushe baki. Da wuya lura heatstroke, agranulocytosis.
contraindications
Na nufin "Etaperazin" umarnin don amfani ba da damar domin ganawa da hepatitis, cirrhosis, hematopoietic cuta, nephritis, hemolytic jaundice, a lokacin lactation. Contraindications pathologies hada kwakwalwa da kuma laka a cikin tsarin irin m Hakika, ciki, bronchiectasis a cikin marigayi lokaci hypersensitivity. Ba da shawarar magani a thromboembolic cututtuka, kamar mataimakin decompensated zuciya. M aiki medicament "Etaperazin" (umurci manual hada da irin data) nuna a Parkinson ta cuta, barasa, abin mãye, cuta na hanta. Kashi gyara iya da ake bukata a predisposition zuwa glaucoma, farfadiya seizures, na kullum irin pathologies na numfashi tsarin. Zama wary ce medicament amfani da magani daga rauni, mai gina jiki da marasa lafiya, tsofaffi da marasa lafiya da kuma yara.
Similar articles
Trending Now